These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16965727)

  • 1. Metabolic safety of antihypertensive drugs: myth versus reality.
    Stas S; Appesh L; Sowers J
    Curr Hypertens Rep; 2006 Oct; 8(5):403-8. PubMed ID: 16965727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
    Scheen AJ
    Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interview with Prof. Peter Dominiak, Lübeck. "Risk of diabetes with antihypertensive drugs is clinically relevant" (interview by Dr. Angelika Bischoff)].
    Dominiak P
    MMW Fortschr Med; 2004 Dec; 146(51-52):51. PubMed ID: 15675248
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive agents, insulin sensitivity, and new-onset diabetes.
    Sarafidis PA; McFarlane SI; Bakris GL
    Curr Diab Rep; 2007 Jun; 7(3):191-9. PubMed ID: 17547836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New-onset diabetes and antihypertensive drugs.
    Mancia G; Grassi G; Zanchetti A
    J Hypertens; 2006 Jan; 24(1):3-10. PubMed ID: 16331092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertension therapy for type 2 diabetics].
    Bönner G
    MMW Fortschr Med; 2007 Jun; 149(23):45, 47-8. PubMed ID: 18062579
    [No Abstract]   [Full Text] [Related]  

  • 8. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of diabetes in hypertensive patients: results and implications from the VALUE trial.
    Zhou MS; Schulman IH
    Vasc Health Risk Manag; 2009; 5(1):361-8. PubMed ID: 19475773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and diabetes in the context of treatment of hypertension.
    Lithell HO
    Blood Press Suppl; 1998; 3():28-31. PubMed ID: 10321452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A; Divchev D; Luchtefeld M; Schieffer B
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiotensin II receptor blockers--evidence along the cardiovascular continuum].
    Zeller A; Battegay E
    Praxis (Bern 1994); 2005 Apr; 94(15):581-94. PubMed ID: 15884724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].
    Middeke M
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2498. PubMed ID: 23168983
    [No Abstract]   [Full Text] [Related]  

  • 15. Complete inhibition of the renin-angiotensin-aldosterone system; where do we stand?
    Chen SS; Seliger SL; Fried LF
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):449-55. PubMed ID: 25014549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance, diabetes, hypertension, and renin-angiotensin system inhibition: reducing risk for cardiovascular disease.
    Fonseca VA
    J Clin Hypertens (Greenwich); 2006 Oct; 8(10):713-20; quiz 721-2. PubMed ID: 17028485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dual blockade of the renin-angiotensin system in hypertensive treatment: no].
    van der Giet M
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2499. PubMed ID: 23168984
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-diabetic effect of blockade of the renin-angiotensin system.
    Ando K; Fujita T
    Diabetes Obes Metab; 2006 Jul; 8(4):396-403. PubMed ID: 16776746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of the renin angiotensin system: proven benefits, unproven safety.
    Parfrey PS
    Ann Intern Med; 2008 Jan; 148(1):76-7. PubMed ID: 17984483
    [No Abstract]   [Full Text] [Related]  

  • 20. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes.
    Jandeleit-Dahm KA; Tikellis C; Reid CM; Johnston CI; Cooper ME
    J Hypertens; 2005 Mar; 23(3):463-73. PubMed ID: 15716683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.